CS logo
small CS logo
Instituto Jalisciense de Investigacion en Diabetes y Obesida

Guadalajara, Jalisco, Mexico
Doctor in Guadalajara
Av. José María Morelos 1952, Ladrón de Guevara, Ladron De Guevara, 44600 Guadalajara, Jal.

About Instituto Jalisciense de Investigacion en Diabetes y Obesida


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
Pfizer
2
Boehringer Ingelheim
1
Gilead Sciences
1
Immunic AG
1
Total Rows: 5

Clinical Trials at Instituto Jalisciense de Investigacion en Diabetes y Obesida


During the past decade, Instituto Jalisciense de Investigacion en Diabetes y Obesida conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000011112233110000000000110022Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
2012-06-01
2013-10-01
Completed
442
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
2015-11-05
2019-03-31
Completed
7,797
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
2019-07-30
2021-02-15
Completed
1,879
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
2020-10-19
2022-11-01
Completed
1,428
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
2021-07-16
2022-04-25
Completed
2,246
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
2021-09-09
2022-04-12
Completed
2,954

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Immunic AG" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 5Eli Lilly and Company: 5Pfizer: 2Pfizer: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Gilead Sciences: 1Gilead Sciences: 1Immunic AG: 1Immunic AG: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Instituto Jalisciense de Investigacion en Diabetes y Obesida


According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Type 2 Diabetes Mellitus" (3 trials), "COVID-19" (2 trials), "Type 2 Diabetes" (2 trials), "Multiple Sclerosis" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" in a lesser frequency.

Clinical Trials Intervention Types at Instituto Jalisciense de Investigacion en Diabetes y Obesida


Most popular intervention types in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Drug" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tirzepatide" (5 trials), "PF-07321332" (2 trials), "Placebo" (2 trials), "Ritonavir" (2 trials) and "Diet" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto Jalisciense de Investigacion en Diabetes y Obesida


The vast majority of trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are 10 trials for "All" genders.

Clinical Trials Status at Instituto Jalisciense de Investigacion en Diabetes y Obesida


Currently, there are NaN active trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Instituto Jalisciense de Investigacion en Diabetes y Obesida, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Jalisciense de Investigacion en Diabetes y Obesida, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1